Evaluating outcomes of pregnancies with genital bleeding after 18 weeks

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the frequency of adverse maternal-fetal outcomes, such as premature birth and maternal-fetal hemorrhage, in pregnancies characterized by genital bleeding beyond 18 weeks. The study will analyze data collected from women attending the obstetric-gynaecological emergency department for this condition. Additionally, it seeks to evaluate the effectiveness of sonographic techniques in identifying the causes of genital bleeding over time, which may lead to improved management and individualized obstetrical care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pregnancy beyond 18 weeks gestational age complicated by genital bleeding;
* Age of the patient ≥18 years;
* Delivery at the O.U. of Obstetrics and Prenatal Age Medicine

Exclusion Criteria:

None

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Bologna, Italy Recruiting

Study contacts

• Principal investigator: Elisa Morganti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Elisa Montaguti, MD
• Email: elisa.montaguti@aosp.bo.it
• Phone: 0512144369

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Uterine artery ligation versus pericervical tourniquet to reduce bleeding during open myomectomy

  This trial will test whether tying the uterine arteries or using a pericervical tourniquet better reduces blood loss during open myomectomy for women with symptomatic uterine fibroids.

  Recruiting Cairo University · Cairo, Al-Manial · NCT07526311

• Low-dose epinephrine with tranexamic acid during knee replacement

  This will test whether giving low-dose epinephrine together with tranexamic acid to people having knee replacement reduces blood loss, clotting complications, and hospital stay.

  Recruiting Phase 4 King Abdullah International Medical Research Center · Riyadh, Riyadh Region · NCT07089251

• Tranexamic acid to reduce bleeding during second-trimester dilation and evacuation

  We will test whether giving prophylactic tranexamic acid before a second-trimester dilation and evacuation reduces bleeding for people aged 18 and older at 18–24 weeks of pregnancy.

  Recruiting at 3 sites Phase 4 University of California, San Diego · San Diego, California and 2 other locations · NCT06820177

• Monitoring transfusions during anesthesia in emergency situations

  This study is looking at how blood transfusions are done during emergency surgeries to help improve future treatment guidelines for patients.

  Recruiting Erasme University Hospital · Anderlecht · NCT06403163

• Investigating how oxytocin works during cesarean deliveries

  This study is testing how oxytocin works during scheduled cesarean deliveries to see if it helps prevent complications like uterine atony in new mothers.

  Recruiting Phase 2 Stanford University · Stanford, California and 1 other locations · NCT05488457

• Using tranexamic acid to reduce blood loss during vaginal hysterectomy

  This study is testing if a local injection of tranexamic acid can help reduce blood loss during vaginal hysterectomy surgeries.

  Recruiting Meir Medical Center · Kfar Saba, Israel and 1 other locations · NCT04760301

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.